Early Vioxx Study Continued Despite Clear Risks
NPR.org, June 8, 2006 · NPR is providing a full transcript of this story.
ROBERT SIEGEL, host: In 2004, Merck pulled its painkiller Vioxx from the market. The drug was causing heart problems, strokes and deaths among patients in a large study that was under way at the time. Merck stopped the study early when those results became clear. Thousands of former Vioxx patients and their families are suing the company. 
· Read The Full Vioxx Article From NPR -->
·
Read All Vioxx (Rofecoxib) News Stories -->